-transparent.png){kind=logo}
Our experience with intracavernous injection of prostaglandin E1 in spinal cord injured patients with neurogenic erectile dysfunction included 15 men. They received testing dosage starting from 5 micrograms with increasing dosage (maximum 20 micrograms) to achieve a rigid erection of Schramek's grade 5 and lasting for at least 20 min. All of them had achieved functional erection adequate for coitus after treatment except one patient who had been proved to have venogenic impotence. We found that intracavernous injection of prostaglandin E1 had significantly improved the erectile condition. No systemic side effect or any other complication was noted except that pain at the injection site was complained of in two patients with incomplete lesion.
S F Tang, and
N K Chu, and
M K Wong
January 1994,
The Clinical investigator,
S F Tang, and
N K Chu, and
M K Wong
January 1990,
Archivos espanoles de urologia,
S F Tang, and
N K Chu, and
M K Wong
October 1994,
Paraplegia,
S F Tang, and
N K Chu, and
M K Wong
January 1989,
VASA. Supplementum,
S F Tang, and
N K Chu, and
M K Wong
February 1999,
International journal of impotence research,
S F Tang, and
N K Chu, and
M K Wong
October 1994,
The Journal of urology,
S F Tang, and
N K Chu, and
M K Wong
February 1996,
International journal of andrology,
S F Tang, and
N K Chu, and
M K Wong
May 1995,
The Journal of urology,
S F Tang, and
N K Chu, and
M K Wong
April 1994,
Harefuah,
S F Tang, and
N K Chu, and
M K Wong
October 1997,
The Journal of urology,
